ClinicalTrials.Veeva

Menu

Study on the Progress of Breast Cancer Cases in Males and the Assessment of Relapse Risk

S

Spanish Breast Cancer Research Group (GEICAM)

Status

Completed

Conditions

Breast Cancer, Male

Study type

Observational

Funder types

Other

Identifiers

NCT03800355
GEICAM/2016-04

Details and patient eligibility

About

An observational, Other Designs (OD) post-marketing, multicenter study, which will obtain retrospective data from male patients diagnosed with invasive breast cancer between 2000 and 2019 in the medical oncology departments of hospitals that are associated with Spanish Breast Cancer Research Group (GEICAM) (using information obtained from patient medical histories).

Full description

One of the objectives of this project is to ensure representativeness of the cases referred to. Accordingly, participating sites agree to enroll in the study male patients who were diagnosed with breast cancer in the period between 2000 and 2019.

Enrollment

777 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male patients diagnosed with primary invasive breast carcinoma between the years 2000-2019, and who have been treated and/or followed up in the Medical Oncology Departments of participating sites.
  • The enrollment of patients who died is allowed.

Exclusion criteria

  • Male patients who do not wish to participate in the study for any reason.

Trial design

777 participants in 1 patient group

Male breast cancer
Description:
The study target population is all cases of male breast cancer (MBC), diagnosed with invasive breast cancer between the years 2000 and 2019, and treated in the Medical Oncology Departments of participating sites.

Trial contacts and locations

54

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems